Rosanna Ruggiero

Jan 23, 2024 | mdpi.com | Rosanna Ruggiero |Annamaria Mascolo |Angela Spezzaferri |Claudia Carpentieri

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

May 30, 2023 | mdpi.com | Annamaria Mascolo |Mario Gaio |Rosanna Ruggiero |Maria Donniacuo

4. DiscussionTo our knowledge, this is the first analysis of pharmacovigilance European data on AF following COVID-19 vaccination. The current study aimed to evaluate the reporting frequency of AF related to COVID-19 vaccines by using data retrieved from the European pharmacovigilance database EV. Overall, we found and analyzed more than 6000 reports describing AF as an AEFI with anti-COVID-19 vaccines collected in the EV database.